Skip to main content
. 2015 Feb 23;41(7):636–648. doi: 10.1111/apt.13121

Figure 3.

Figure 3

Mean steady-state intragastric pH vs. time profiles after TAK-438 on Day 7 in the Japanese (left) and UK studies (right) in healthy male subjects receiving TAK-438 10–40 mg once daily after overnight fasting at a fixed dose level for 7 consecutive days (Pharmacodynamic analysis set: Japan N = 60; UK N = 48).

HHS Vulnerability Disclosure